Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2021.577664 ◽

2021 ◽

pp. 577664

Author(s):

Max Mimpen ◽

Jan Damoiseaux ◽

William van Doorn ◽

Linda Rolf ◽

Anne-Hilde Muris ◽

...

Keyword(s):

Multiple Sclerosis ◽

B Cells ◽

Interferon Beta ◽

Transitional B Cells ◽

Multiple Sclerosis Patients

Download Full-text

B cell-activating factor of the TNF family expands circulating transitional B cells in multiple sclerosis patients treated with fingolimod

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.2224 ◽

2017 ◽

Vol 381 ◽

pp. 788

Author(s):

Y. Miyazaki ◽

M. Niino ◽

E. Takahashi ◽

T. Fukazawa ◽

I. Amino ◽

...

Keyword(s):

Multiple Sclerosis ◽

B Cells ◽

B Cell ◽

Transitional B Cells ◽

B Cell Activating Factor ◽

Multiple Sclerosis Patients

Download Full-text

Combining capture ELISA and in vivo MxA test to detect neutralizing antibodies to interferon-beta in a large cohort of multiple sclerosis patients

Aktuelle Neurologie ◽

10.1055/s-2007-987508 ◽

2007 ◽

Vol 34 (S 2) ◽

Author(s):

K Bulat ◽

S Cepok ◽

G von Geldern ◽

S Hochgesand ◽

T Menge ◽

...

Keyword(s):

Multiple Sclerosis ◽

Neutralizing Antibodies ◽

Interferon Beta ◽

Large Cohort ◽

Capture Elisa ◽

Multiple Sclerosis Patients

Download Full-text

Depression in interferon-beta treated multiple sclerosis patients

10.26226/morressier.5b681764b56e9b005965bff9 ◽

2018 ◽

Author(s):

Renato Guedes ◽

Maria Celeste Sousa Silveira

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Multiple Sclerosis Patients

Download Full-text

Faculty Opinions recommendation of Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732046430.793556748 ◽

2019 ◽

Author(s):

David Selwood

Keyword(s):

Multiple Sclerosis ◽

B Cells ◽

Plasma Cells ◽

Memory B Cells ◽

Transitional B Cells

Download Full-text

PND44 Assessing Variations in Transitions in Employment in Relapsing-Remitting Multiple Sclerosis Patients Treated With Either Laquinimod, Interferon Beta 1-a or Placebo: Expoloratory Evidence From the United States Substudy of Bravo

Value in Health ◽

10.1016/j.jval.2012.03.803 ◽

2012 ◽

Vol 15 (4) ◽

pp. A149

Author(s):

C.A. Carroll ◽

M.A. Oleen-Burkey

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Interferon Beta ◽

The United States ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

THD-Tricluster method on gene expression data of multiple sclerosis patients receiving interferon-beta therapy

10.1063/5.0058711 ◽

2021 ◽

Author(s):

A. D. Rachma ◽

S. M. Soemartojo ◽

T. Siswantining

Keyword(s):

Gene Expression ◽

Multiple Sclerosis ◽

Gene Expression Data ◽

Interferon Beta ◽

Expression Data ◽

Multiple Sclerosis Patients

Download Full-text

Cellular immune responses in multiple sclerosis patients treated with interferon-beta

Clinical & Experimental Immunology ◽

10.1111/cei.12016 ◽

2013 ◽

Vol 171 (3) ◽

pp. 243-246 ◽

Author(s):

M. F. Bustamante ◽

J. Rio ◽

Z. Castro ◽

A. Sánchez ◽

X. Montalban ◽

...

Keyword(s):

Multiple Sclerosis ◽

Immune Responses ◽

Interferon Beta ◽

Cellular Immune Responses ◽

Multiple Sclerosis Patients ◽

Cellular Immune

Download Full-text

Genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting multiple sclerosis patients

Scientific Reports ◽

10.1038/s41598-018-35603-0 ◽

2018 ◽

Vol 8 (1) ◽

Author(s):

Vicki E. Maltby ◽

Rodney A. Lea ◽

Moira C. Graves ◽

Katherine A. Sanders ◽

Miles C. Benton ◽

...

Keyword(s):

Multiple Sclerosis ◽

Dna Methylation ◽

B Cells ◽

Genome Wide ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Brain volume loss and no evidence of disease activity over 3 years in multiple sclerosis patients under interferon beta 1a subcutaneous treatment

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2018.10.095 ◽

2019 ◽

Vol 59 ◽

pp. 175-178

Author(s):

J.I. Rojas ◽

F. Sanchez ◽

F. Caro ◽

J. Miguez ◽

L. Patrucco ◽

...

Keyword(s):

Multiple Sclerosis ◽

Disease Activity ◽

Interferon Beta ◽

Brain Volume ◽

Volume Loss ◽

Brain Volume Loss ◽

Multiple Sclerosis Patients

Download Full-text

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study

Advances in Therapy ◽

10.1007/s12325-018-0799-5 ◽

2018 ◽

Vol 35 (11) ◽

pp. 1894-1904 ◽

Author(s):

Stanley Cohan ◽

Kyle Smoot ◽

Kiren Kresa-Reahl ◽

Robert Garland ◽

Wei-Shi Yeh ◽

...

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Claims Database ◽

Database Study ◽

Multiple Sclerosis Patients

Download Full-text